BOKU | IBSE’s Post

Amsterdam-based Cradle an AI-powered platform revolutionizing protein engineering, has secured $73 million in Series B funding to meet growing demand in research-intensive industries. Led by IVP with Index Ventures and Kindred Capital participation, the latest round brings Cradle’s total funding to over $100 million. The latest investment will support Cradle’s mission to enable scientists to engineer proteins more efficiently, addressing challenges across therapeutics, diagnostics, food, chemicals, and agriculture. Industry leaders such as Novo Nordisk and Johnson & Johnson are already leveraging Cradle’s generative AI platform to accelerate innovation.

🔬 Implementing alternative methods for adventitious agents can slash >90% of testing time and realize cost savings of up to $5 million per product , but their adoption has been slow. 📰 The BioPhorum paper ‘A Structured Approach For The Evaluation, Validation And Implementation Of Nat-Based Mycoplasma Detection Methods’, published in 2023 by the Technology Strategy Phorum has been summarised by Life Science Connect and details a best practice 9 step framework for adoption of NAT-Based Mycoplasma Detection Methods. #Mycoplasma #BioPhorum Life Science Connect Bioprocess Online https://lnkd.in/e7TM-7Tg ✍🏻 Authors: ✍🏾 ·      BioMérieux Félix A MONTERO-JULIAN PhD ·      Lonza Antonietta Corrado, Eva Tur García ·      Merck (Health Care Business Sector) Cristina Barbirato ·      Merck (Life Science Business Sector) Rob Goodier , Donna McMutrie ·      Novo Nordisk Annette Jørgensen ·      Pall Biotech Morven McAlister ·      Roche/Genentech Sven Deutschmann, Kevin McCarthy ·      Sanofi Thierry Bonnevay ·      Sartorius Stedim Dr. Miriam Dormeyer ·      Thermo Fisher Scientific Mike Brewer ☑ Reviewers: ☑ ·      Asahi Kasei Daniel Strauss ·      BioMérieux Philippe GADAL, Arnaud PARIS - Pharma Quality Control ·      Bioprocessing Technology Institute, Agency for Science, Technology and Research Andre Choo ·      FUJIFILM Diosynth Biotechnologies WILLIAMS KWAME NKRUMAH, LLM ·      Janssen Karen De Roy ·      Novo Nordisk Corinna Cavan Pedersen

SEED Biosciences is excited to be exhibiting at SLAS 2025 International Conference & Exhibition on 25-29 January in San Diego, USA! Visit us at Booth #2217 to explore how our innovative technologies are advancing single cell analysis and accelerating scientific discoveries. 🔬 At our booth, we'll be showcasing two of our cutting-edge technologies: 1️⃣ DispenCell-S4: Our single cell dispenser with advanced automation and superior design for streamlined integration into GMP-compatible workflows, simplifying the transition to regulated processes. Its reliable proof of monoclonality surpasses FDA standards. 2️⃣ Dispen3D: Our award-winning benchtop robot that allows scientists to isolate spheroids and organoids efficiently, reliably and cost-effectively. It enables scientist to conduct high-precision experiments that drive advancements in drug discovery, personalized medicine, and regenerative therapies. We look forward to connecting with researchers, industry leaders and innovators to explore new opportunities in biotechnology and discuss how our solutions can support your research and development goals. ✅ #SLAS2025 #SingleCellResearch #Biotechnology #LifeSciences #ResearchInnovation #SLAS #Spheroids #CellLineDevelopment #TopClones #Monoclonality #FDA #GMP SLAS (Society for Laboratory Automation and Screening)

Terry Ernest and Maciej Krause are looking forward to attending Bio Integrates in Cambridge on 15th May. Book a meeting with them or stop by the Almac booth to discuss your project. Find out more about our development and manufacturing solutions, and how we can partner with you to support your pipeline. https://hubs.li/Q02wwtRY0 #BioIntegrates2024 Life Science Integrates

🌟 BioStem Technologies is proud to lead the way! 🌟 We’re honored to be a Leadership Member at the Florida Innovation Conference, powered by BioFlorida, happening now! This event brings together trailblazers in biotechnology, life sciences, and healthcare innovation—and we’re thrilled to share insights and collaborate with like-minded professionals driving the future of medicine. 🔗 Learn more and join the conversation: https://lnkd.in/dpq-4xh Stay tuned for highlights from the conference and updates on how BioStem is making an impact in advancing regenerative medicine. 💡🌱 #BioStemTechnologies #FloridaInnovation #BioFlorida #RegenerativeMedicine #LifeSciences #InnovationLeadership #BSEM BioFlorida, Inc.

MiRACULOUS Progress: RSL Revolutionary Labs Update Where We Are Now – Driving Innovation in Chronic Wound Care As part of the groundbreaking MiRACULOUS Project, RSL Revolutionary Labs is proud to share our latest progress in developing advanced therapies for chronic wound management. Current Milestones: ✔️  Scientific Research: Conducted extensive studies into the properties and efficacy of natural extracts, focusing on their antimicrobial, anti-inflammatory, and wound-healing mechanisms. ✔️Custom Extract Preparation: Created tailored extract formulations to meet the unique requirements of this innovative therapeutic approach. ✔️ R&D Trials: Launched rigorous trials to optimize the final gel formulation, ensuring safety, efficacy, and alignment with the project’s objectives. Through collaborative efforts with Promed Bioscience and Theramir Ltd, we’re advancing a synergistic solution that blends natural innovation with cutting-edge biotechnology to improve patient outcomes worldwide. *This project receives funding from the Ίδρυμα Έρευνας και Καινοτομίας/Research and Innovation Foundation #MiRACULOUSProject #RSLRevolutionaryLabs #ChronicWoundCare #NaturalInnovation #Biotechnology

🧬 The UK Government's Life Science strategy is designed to propel the nation to the forefront of global life sciences. By investing in innovative research, the plan aims to accelerate the development of treatments and technologies. 🥽 What does our Recirculating Technology and the Circulaire® Fume Cupboard offer the Life Science sector? ✅ Enhanced Safety: Offers advanced operator protection through Activated Carbon filtration technology, tailored specifically to your application’s requirements. ✅ Recirculating Technology: Sustainable clean air technologies efficiently capture harmful substances at source, cleaning the airflow of contaminants and offering protection to the environment. ✅ Flexible Installation: Can be installed anywhere in your lab or research facility without the need for external ducting, allowing for easy integration into your existing workspace. ✅ Customisable Options: Available in both standard and custom configurations to meet the unique demands of your research laboratory. ℹ️ Learn more about our Fume Cupboards: https://bit.ly/3JUHl5M #LifeSciences #Biotechnology #Pharmaceuticals #MedicalResearch #Genomics #Bioengineering #ClinicalResearch #DrugDiscovery #HealthcareTechnology #BiomedicalScience #CellBiology #Genetics | SDI Group

In a webinar, Greg Dodge—formerly of the Massachusetts Institute of Technology Imperiali lab—shared transformative insights into using copolymers in membrane protein research. This short clip is a key highlight from his session. Greg explains, "𝗜𝗳 𝘄𝗲 𝘀𝘄𝗶𝘁𝗰𝗵 𝘁𝗼 𝘂𝘀𝗶𝗻𝗴 𝗦𝗠𝗔 [𝗮𝗻𝗱 𝗼𝘁𝗵𝗲𝗿 𝗰𝗼𝗽𝗼𝗹𝘆𝗺𝗲𝗿 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀] 𝗶𝗻𝘀𝘁𝗲𝗮𝗱 𝗼𝗳 𝗱𝗲𝘁𝗲𝗿𝗴𝗲𝗻𝘁𝘀 (𝗹𝗶𝗸𝗲 𝗗𝗗𝗠), 𝘄𝗲 𝗰𝗮𝗻 𝗮𝗰𝘁𝘂𝗮𝗹𝗹𝘆 𝘀𝗼𝗹𝘂𝗯𝗶𝗹𝗶𝘇𝗲 𝗮𝗻𝗱 𝗽𝘂𝗿𝗶𝗳𝘆 𝗔𝗟𝗟 𝗼𝗳 𝗼𝘂𝗿 𝗺𝗲𝗺𝗯𝗿𝗮𝗻𝗲 𝗽𝗿𝗼𝘁𝗲𝗶𝗻 𝘁𝗮𝗿𝗴𝗲𝘁𝘀." This revelation becomes even more compelling when he presents his data: a table showing that while detergents solubilized only a fraction of his membrane proteins, copolymers succeeded across the board. It's clear that this new technology is vastly superior for extracting proteins in their functional, native-like states. Greg’s work emphasizes a critical paradigm shift: moving away from traditional detergent-based methods and embracing advanced copolymer technologies for a more reliable and versatile approach to membrane protein research. At Cube Biotech, we’re excited to push these boundaries even further. Our next-generation copolymers, including Cubipols and Biotiny copolymers, are designed to deliver higher efficiency and functionality for membrane protein solubilization, purification, and structural studies.

Fondazione Edmund Mach, the coordinator of this project, is leveraging its expertise in plant genomics, BACs, and environmental monitoring to drive innovation in the sustainable production of bioactive compounds from bryophytes. As the lead partner, their research will be pivotal in establishing the foundation for developing these compounds for the cosmetic, agro-food, and pharmaceutical industries. Learn more about our team: https://lnkd.in/eMSDaHnY

In 2024, ATCC contributed to advancing scientific research in many ways. Some highlights include: - Offered several innovative new products: MicroQuant™ , ThawReady™ , and HepatoXcell™ -Hosted 15 webinars highlighting innovative research -Presented 37 scientific posters -Helped food manufacturers and stakeholders advance scientific knowledge in the field of food production and biotechnology. We’re excited to share more highlights in our upcoming #blog next Wednesday. #2024 #ATCCHighlights2024 #AnIncredibleYear